Chevé G - Search Results

1

Structural elucidation of the DFG-Asp in and DFG-Asp out states of TAM kinases and insight into the selectivity of their inhibitors.

Messoussi A, Peyronnet L, Feneyrolles C, Chevé G, Bougrin K, Yasri A. Messoussi A, et al. Among authors: cheve g. Molecules. 2014 Oct 10;19(10):16223-39. doi: 10.3390/molecules191016223. Molecules. 2014. PMID: 25310149 Free PMC article.

2

Recent progress in the design, study, and development of c-Jun N-terminal kinase inhibitors as anticancer agents.

Messoussi A, Feneyrolles C, Bros A, Deroide A, Daydé-Cazals B, Chevé G, Van Hijfte N, Fauvel B, Bougrin K, Yasri A. Messoussi A, et al. Among authors: cheve g. Chem Biol. 2014 Nov 20;21(11):1433-43. doi: 10.1016/j.chembiol.2014.09.007. Epub 2014 Oct 16. Chem Biol. 2014. PMID: 25442375 Review.

3

Discovering novel 7-azaindole-based series as potent AXL kinase inhibitors.

Feneyrolles C, Guiet L, Singer M, Van Hijfte N, Daydé-Cazals B, Fauvel B, Chevé G, Yasri A. Feneyrolles C, et al. Among authors: cheve g. Bioorg Med Chem Lett. 2017 Feb 15;27(4):862-866. doi: 10.1016/j.bmcl.2017.01.015. Epub 2017 Jan 9. Bioorg Med Chem Lett. 2017. PMID: 28094183

4

Axl kinase as a key target for oncology: focus on small molecule inhibitors.

Feneyrolles C, Spenlinhauer A, Guiet L, Fauvel B, Daydé-Cazals B, Warnault P, Chevé G, Yasri A. Feneyrolles C, et al. Among authors: cheve g. Mol Cancer Ther. 2014 Sep;13(9):2141-8. doi: 10.1158/1535-7163.MCT-13-1083. Epub 2014 Aug 19. Mol Cancer Ther. 2014. PMID: 25139999 Review.

5

Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors.

Daydé-Cazals B, Fauvel B, Singer M, Feneyrolles C, Bestgen B, Gassiot F, Spenlinhauer A, Warnault P, Van Hijfte N, Borjini N, Chevé G, Yasri A. Daydé-Cazals B, et al. Among authors: cheve g. J Med Chem. 2016 Apr 28;59(8):3886-905. doi: 10.1021/acs.jmedchem.6b00087. Epub 2016 Apr 15. J Med Chem. 2016. PMID: 27010810

6

Recent advances in drug design of epidermal growth factor receptor inhibitors.

Warnault P, Yasri A, Coisy-Quivy M, Chevé G, Boriès C, Fauvel B, Benhida R. Warnault P, et al. Among authors: cheve g. Curr Med Chem. 2013;20(16):2043-67. doi: 10.2174/0929867311320160001. Curr Med Chem. 2013. PMID: 23410174 Review.

7

Design, synthesis, and biological evaluation of bifunctional thyrointegrin inhibitors: new anti-angiogenesis analogs.

Bridoux A, Khan RA, Chen C, Chevé G, Cui H, Dyskin E, Yasri A, Mousa SA. Bridoux A, et al. Among authors: cheve g. J Enzyme Inhib Med Chem. 2011 Dec;26(6):871-82. doi: 10.3109/14756366.2011.557023. Epub 2011 Mar 14. J Enzyme Inhib Med Chem. 2011. PMID: 21395488

8

Determination and validation of mTOR kinase-domain 3D structure by homology modeling.

Lakhlili W, Chevé G, Yasri A, Ibrahimi A. Lakhlili W, et al. Among authors: cheve g. Onco Targets Ther. 2015 Jul 30;8:1923-30. doi: 10.2147/OTT.S84200. eCollection 2015. Onco Targets Ther. 2015. PMID: 26257525 Free PMC article.

9

A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist.

Singh N, Chevé G, Ferguson DM, McCurdy CR. Singh N, et al. Among authors: cheve g. J Comput Aided Mol Des. 2006 Jul-Aug;20(7-8):471-93. doi: 10.1007/s10822-006-9067-x. Epub 2006 Sep 29. J Comput Aided Mol Des. 2006. PMID: 17009091

10

Comparative protein modeling of 1-deoxy-D-xylulose-5-phosphate reductoisomerase enzyme from Plasmodium falciparum: a potential target for antimalarial drug discovery.

Singh N, Chevé G, Avery MA, McCurdy CR. Singh N, et al. Among authors: cheve g. J Chem Inf Model. 2006 May-Jun;46(3):1360-70. doi: 10.1021/ci050523w. J Chem Inf Model. 2006. PMID: 16711755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page